These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20958104)

  • 1. Pharmacological treatment of obesity in children and adolescents: current status and perspectives.
    Catoira N; Nagel M; Di Girolamo G; Gonzalez CD
    Expert Opin Pharmacother; 2010 Dec; 11(18):2973-83. PubMed ID: 20958104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic options for overweight adolescents.
    Dunican KC; Desilets AR; Montalbano JK
    Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications for weight reduction.
    Bray GA
    Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [No progress without the physician in therapy of obesity].
    Schmidt H; Plauth M
    MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
    [No Abstract]   [Full Text] [Related]  

  • 7. Combining behavioral and pharmacological treatments for obesity.
    Phelan S; Wadden TA
    Obes Res; 2002 Jun; 10(6):560-74. PubMed ID: 12055334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ; Wilton LV; Shakir SA
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for weight management.
    Palatty PL; Saldanha E
    J Assoc Physicians India; 2012 Mar; 60():34-40, 45. PubMed ID: 22799113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic agents for the treatment of obesity.
    Mathys M
    Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long way towards a successful drug treatment of obesity].
    Rössner S
    Lakartidningen; 2011 Dec 7-13; 108(49):2578-80. PubMed ID: 22468394
    [No Abstract]   [Full Text] [Related]  

  • 13. [The principle of precaution and the drug treatment of obese subjects].
    C-Soriguer FJ; Tinahones FJ
    Med Clin (Barc); 1999 Apr; 112(13):503-7. PubMed ID: 10353118
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the pharmacological treatment of obesity.
    Schnee DM; Zaiken K; McCloskey WW
    Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of obesity.
    Linné Y; Rössner S
    Clin Dermatol; 2004; 22(4):319-24. PubMed ID: 15475233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
    Fujioka K
    Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of obesity].
    Svendsen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-obesity drugs: use, mechanisms and clinical importance.
    Adam O; Forth W
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ; Ernest P
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.